Live Breaking News & Updates on Michaelr Debaun

Stay updated with breaking news from Michaelr debaun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reporting on a Child's Fight to Survive - The New York Times

John Eligon, a correspondent for The Times, examined the obstacles of caring for children with sickle cell disease in developing nations. ....

John Eligon , Sickle Cell Anemia , Clinical Trial , Michaelr Debaun , Kano Nigeria , The New York Times ,

Researchers Halt Trial of Promising Sickle Cell Treatment


Researchers Halt Trials of Promising Sickle Cell Treatment
Two patients in a gene therapy study developed cancer years after treatment. It is not clear whether the therapy was responsible.
Researchers working in the cellular and molecular therapeutics branch at the National Heart, Lung and Blood Institute in Bethesda, Md.Credit.Erin Scott/Reuters
Feb. 22, 2021
Just when it seemed that a new gene therapy for sickle cell disease was sailing toward success, the company developing the treatment found that two patients now have cancer and halted the trial.
A patient who was treated five and a half years ago has developed myelodysplastic syndrome, a form of cancer that is often a precursor to leukemia, Bluebird Bio reported, while another has developed acute myeloid leukemia. ....

United States , San Antonio , University Of Texas , Davida Williams , Johnf Tisdale , Melissaj Frei Jones , Michaelr Debaun , Drug Administration , Vanderbilt Meharry Matthew Walker Center , National Heart , Blood Institute , University Of Texas School Medicine , Bluebird Bio , Texas School , Boston Children , Sickle Cell , Sickle Cell Anemia , Genetic Engineering , Bone Marrow , Clinical Trial , Lung And Blood Institute , Black People African American , ஒன்றுபட்டது மாநிலங்களில் , சான் அன்டோனியோ , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் , டேவிடா வில்லியம்ஸ் ,